OIT3

OIT3

Target · Liver-associated protein

OIT3 Oncoprotein induced transcript 3 · LZP

OIT3 (oncoprotein induced transcript 3, also known as LZP and FLJ39116) is a human protein that may be involved in hepatocellular function and development. The OIT3 gene was identified because its expression is downregulated in hepatocarcinomas. Browse Assay Genie's current range of OIT3 research reagents below, or read on for the biology behind the target.

Nucleus envelope proteinPutative liver function roleDownregulated in hepatocarcinoma
545 aa
Protein length
~60 kDa
Molecular weight
10q22.1
Gene locus
Liver-linked
Functional context
Target information

What is OIT3 (oncoprotein induced transcript 3)?

OIT3 is a protein whose precise molecular mechanism has not been defined in the sources used for this page. The UniProt annotation states only that it may be involved in hepatocellular function and development, and the NCBI Gene summary similarly proposes a role in liver development and function. Researchers studying OIT3 therefore tend to approach it as a liver-associated protein, using an OIT3 antibody, OIT3 ELISA kit or recombinant OIT3 protein to examine where and how it is present in experimental systems.

UniProt records the subcellular location of oncoprotein-induced transcript 3 protein as the nucleus envelope. The human OIT3 gene is the subject of HGNC entry HGNC:29953, NCBI Gene entry 170392 and UniProt entry Q8WWZ8, and orthologous genes named Oit3 are recorded in both mouse and rat. This makes rodent models a natural route for investigating the OIT3 gene and its product, although conservation of function should be confirmed experimentally.

The OIT3 gene was identified because of its downregulation in hepatocarcinomas, which is the origin of the link between this protein and liver cancer research. The approved name, oncoprotein induced transcript 3, reflects the way the gene was first described. It is also listed under the aliases LZP and FLJ39116, which may appear in older publications and database records. Beyond its reduced expression in hepatocarcinoma and its proposed role in liver development and function, further details on OIT3 biology remain to be established.

Hepatocellular carcinoma research

OIT3 was identified through its downregulation in hepatocarcinomas, making it a candidate for studies of gene expression changes in liver tumours.

Liver development studies

The protein may be involved in liver development, so OIT3 is relevant to work on how hepatic tissue forms and matures.

Hepatocellular function

OIT3 may contribute to hepatocellular function, giving researchers a target for investigating normal liver cell biology.

Nuclear envelope biology

UniProt places OIT3 at the nucleus envelope, which frames questions about its subcellular localisation and associated cellular roles.

Background

OIT3 frequently asked questions

What does OIT3 do?

The function of OIT3 is not fully defined. UniProt states that it may be involved in hepatocellular function and development, and the NCBI Gene summary says the encoded protein may be involved in liver development and function. Its subcellular location is recorded as the nucleus envelope.

What other names does OIT3 go by?

OIT3 stands for oncoprotein induced transcript 3, the approved HGNC name. The protein is named oncoprotein-induced transcript 3 protein in UniProt. Aliases include LZP and FLJ39116, which you may meet in older literature or database entries.

Why is OIT3 linked to liver cancer?

The OIT3 gene was identified because it is downregulated in hepatocarcinomas, according to the NCBI Gene summary. Mouse and rat orthologs are both named Oit3; check the datasheet of any product for its validated reactivity.

Explore

Related targets

Liver-associated proteins and hepatocellular carcinoma markers that are often studied alongside OIT3.

Gene and protein annotations from HGNC, NCBI Gene and UniProt Q8WWZ8; product specifications from Assay Genie datasheets.

OIT3 Product listing